All News

Adding endorectal magnetic resonance imaging to the initial clinical evaluation of men with clinically low prostate cancer risk helps assess these patients' eligibility for active surveillance, according to a recent study.

This special installment of "Hands On" is presented in a point-counterpoint format, with two leading experts discussing open versus. robot-assisted radical prostatectomy.

Participants in the American Association of Clinical Urologists' recent 5th Annual State Society Network Advocacy Conference took home valuable tools to improve their advocacy efforts and influence policymakers in their home state.

One-third of men with high-risk prostate cancer achieved pathologic complete response (pCR) or near-complete response to 6 months of preoperative therapy with abiraterone acetate (ZYTIGA), leuprolide, and prednisone, investigators reported at the American Society of Clinical Oncology annual meeting in Chicago.

Standard laparoscopic procedures are associated with more muscular contraction and trapezius muscle fatigue than robot-assisted approaches, according to a comparison of the two approaches conducted by 11 surgeons.

External application of pulsed electromagnetic fields using an investigational device (TranStim Transdermal Neuromodulation System, EMKinetics, Inc., Mountain View, CA) produces the same stimulation of the posterior tibial nerve as traditional electrical stimulation, results from a proof-of-concept study demonstrate.

High quantities of aberrantly expressed genes are predictive of tumor aggressiveness and poor oncologic outcomes in patients with clear cell renal cell carcinoma, according to a recent study.

The latest urology products and services from American Medical Systems and Covidien.

Older patients with early-stage kidney cancer had significant improvement in short-term survival after partial versus radical nephrectomy but no long-term survival benefit, data from a large retrospective study showed.

Zero-ischemia robotic partial nephrectomy appears to be feasible and safe, findings from a pilot study analyzing prospectively collected data in an institutional review board-approved database show.

Women taking atypical antipsychotic medications have about a threefold higher prevalence of lower urinary tract symptoms (LUTS) compared to nonusers, a recent study has found.

A study from Weill Cornell Medical College, New York suggests patients with metabolic syndrome may be at increased risk for clear cell renal cell carcinoma.

Salvage high-intensity focused ultrasound (HIFU) appears to be an effective treatment option for locally recurrent prostate cancer after primary external beam radiation therapy (EBRT), data from analyses of 6-year oncologic outcomes show.

The treatment benefit of intradetrusor onabotulinumtoxinA (Botox) for urinary incontinence due to neurogenic detrusor overactivity may decline after patients have received multiple repeat injections, findings from a study by Taiwanese urologists suggest.

With the presidential election looming, we thought it would be appropriate to look at the visions for health care reform put forth by the two presidential candidates, with an eye toward what a urology practice should do today to prepare for the future.

Adoption of robotic surgery for treatment of kidney cancer has led to a modest increase in the annual volume of partial nephrectomies but a substantial cost savings for care of chronic kidney disease, an economic analysis of a 6-year period suggests.

There is never a bad time to revisit the beneficiary designations you have made over the years.

While most of the urologists we interviewed use non-physician providers, they don't believe these practitioners are adequately trained to do cystoscopy.

Patients with early-stage kidney cancer fared much better with partial rather than radical nephrectomy if they were candidates for either procedure, say researchers from the University of Michigan, Ann Arbor.

Responders to the multi-targeted receptor tyrosine kinase inhibitor sunitinib (Sutent) have significantly longer progression-free survival and overall survival than non-responders, according to an analysis of 1,059 patients who participated in six clinical trials of sunitinib as first- or second-line therapy of metastatic renal cell carcinoma.

It's hard to argue with the statement that no ischemia is probably better than some ischemia, but at what cost?

While it is still far from clear how specialists will adapt to the accountable care organization, and it seems likely that+M51 ACOs will take different shapes and forms, a sense of inevitability has settled in and urologists need to prepare themselves for change.

An underfilled schedule and increasing no-show rate are just two of the pitfalls to avoid.

Howard Goldman, MD, discusses the possible effects of FDA reclassification of transvaginal mesh used for prolapse as well as the importance of adequate surgical training and patient selection.

An implantable neurostimulator (InterStim, Medtronic, Minneapolis) improves voiding outcomes in patients with voiding dysfunction that is refractory to other therapies, a retrospective long-term follow-up of patients at a single center showed.

The recently published meaningful use Stage 2 final rule will directly affect urology practices.

Urologists share some simple methods and techniques that make their job easier.

Osteoporosis, pelvic organ prolapse, and incontinence are common in postmenopausal women and may share a common pathway, a recent study suggests.

Results of a recent study support the use of barbed polyglyconate sutures to facilitate vesicourethral anastomosis (VUA) during robot-assisted radical prostatectomy.

A biopsy-based genomic assay that would discriminate between aggressive prostate cancer and indolent disease to guide treatment decisions is under development.